Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.
Tarumi R, Tsugawa S, Noda Y, Plitman E, Honda S, Matsushita K, Chavez S, Sawada K, Wada M, Matsui M, Fujii S, Miyazaki T, Chakravarty MM, Uchida H, Remington G, Graff-Guerrero A, Mimura M, Nakajima S.
Tarumi R, et al. Among authors: chavez s.
Neuropsychopharmacology. 2020 Mar;45(4):632-640. doi: 10.1038/s41386-019-0589-z. Epub 2019 Dec 16.
Neuropsychopharmacology. 2020.
PMID: 31842203
Free PMC article.